The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bonanni Fabrizio since 2008.
The trader's CIK number is 1183903.
At the time of the last reporting, Bonanni Fabrizio was the EVP, Operations of Amgen Inc. (stock ticker symbol AMGN).
Also see all insider trading activities at Amgen Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | AMGN | 0 | $0 | 379,465 | $30,339,252 | 353,011 | $20,213,338 |
| 2011 | AMGN | 0 | $0 | 10,000 | $581,230 | 0 | $0 |
| 2009 | AMGN | 0 | $0 | 16,705 | $912,262 | 0 | $0 |
| 2008 | AMGN | 0 | $0 | 40,032 | $2,251,324 | 75,000 | $2,876,999 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-07-27 | AMGN | Option Ex | 303,011 | 57.04 | 17,282,838 |
| 2012-07-27 | AMGN | Sale | 303,011 | 82.14 | 24,888,717 |
| 2012-07-30 | AMGN | Sale | 12,137 | 84.33 | 1,023,561 |
| 2012-05-03 | AMGN | Sale | 6,572 | 70.87 | 465,751 |
| 2012-02-01 | AMGN | Sale | 7,745 | 69.64 | 539,323 |
| 2012-01-27 | AMGN | Option Ex | 50,000 | 58.61 | 2,930,500 |
| 2012-01-27 | AMGN | Sale | 50,000 | 68.44 | 3,421,900 |
| 2011-11-08 | AMGN | Sale | 10,000 | 58.12 | 581,230 |
| 2009-11-23 | AMGN | Sale | 5,351 | 56.01 | 299,714 |
| 2009-11-05 | AMGN | Sale | 11,354 | 53.95 | 612,548 |
| 2008-12-03 | AMGN | Option Ex | 32,393 | 38.36 | 1,242,595 |
| 2008-12-03 | AMGN | Sale | 32 | 56.05 | 1,793 |
| 2008-10-30 | AMGN | Option Ex | 2,607 | 38.36 | 100,004 |
| 2008-10-23 | AMGN | Option Ex | 40,000 | 38.36 | 1,534,400 |
| 2008-10-23 | AMGN | Sale | 24,800 | 56.18 | 1,393,239 |
| 2008-10-23 | AMGN | Sale | 15,200 | 56.34 | 856,292 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bonanni Fabrizio (EVP, Operations of Amgen Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.